Search - tctmd.com

Displaying 41 - 60 of 100

Sort: Relevancy | Date

Presentation TCT 2024

PASCAL Case Presentation #3 and Discussion

Presenter: Sammy Elmariah

October 28, 2024

Presentation TCT 2024

PASCAL Case Presentation #2 and Discussion

Presenter: Molly Szerlip

October 28, 2024

Presentation TCT 2024

EVOQUE system overview & case review

Presenter: Pedro Villablanca

October 28, 2024

Presentation TCT 2024

PASCAL Case Presentation #1 and Discussion

Presenter: Jorge Castellanos

October 28, 2024

Presentation TCT 2024

PASCAL Precision system latest clinical data & predictability study

Presenter: Sam Dawkins

October 28, 2024

Presentation TCT 2024

TCT 1461: Navigating Unchartered Waters: Successful Management of RV Pseudoaneurysm Post VIV TTVR in a High-Risk Tricuspid Valve Patient

Presenter: Huseyin Arman

October 28, 2024

Presentation TCT 2024

TCT 1247: A Novel TTVR System in a Patient Presenting With Challenging Right Heart Anatomy

Presenter: Anita Asgar

October 27, 2024

News Features

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

L.A. McKeown

August 09, 2024

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

L.A. McKeown

August 01, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Presenter: Michael I. Brener

June 07, 2024

Presentation NY Valves 2024

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Presenter: Azeem Latib

June 07, 2024

Presentation NY Valves 2024

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Presenter: Rishi Puri

June 07, 2024

Presentation NY Valves 2024

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Presenter: Elaine Wan

June 07, 2024

Presentation NY Valves 2024

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Presenter: Gian Paolo Ussia

June 06, 2024

Presentation NY Valves 2024

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

Presenter: Wojtek Wojakowski

June 06, 2024

Presentation NY Valves 2024

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Presenter: Brian P. O'Neill

June 06, 2024

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

TricValve: Technology and Clinical Update

Presenter: Rishi Puri

June 06, 2024

Advertisement

PASCAL Case Presentation #3 and Discussion

PASCAL Case Presentation #2 and Discussion

EVOQUE system overview & case review

PASCAL Case Presentation #1 and Discussion

PASCAL Precision system latest clinical data & predictability study

TCT 1461: Navigating Unchartered Waters: Successful Management of RV Pseudoaneurysm Post VIV TTVR in a High-Risk Tricuspid Valve Patient

TCT 1247: A Novel TTVR System in a Patient Presenting With Challenging Right Heart Anatomy

Initial US Commercial TriClip Cases Offer Hope, but Reimbursement Still a Big Question

August 2024 Dispatch for the CV Team

TCTMD’s Top 10 Most Popular Stories for June 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

RV Failure After TTVR: Frequency, Diagnosis, and Therapeutic Options

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

Conduction Abnormalities and Heart Block Post-TTVR: Prognostic Assessment and Therapeutic Options

Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience

Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial

EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

TricValve: Technology and Clinical Update

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content